L-Methionine

Methionine is one of the nine amino acids the body cannot make, supplied mostly by eggs, fish, poultry, dairy and Brazil nuts. Its interest here is positional rather than pharmacological: it is the entry point to one-carbon metabolism, and essentially every methyl group transferred anywhere in human biology passes through it ^[2].

The dose-response is the whole safety story. Nutritional studies at and above requirement have not reported adverse effects in adults and children ^[1], but a methionine load raises homocysteine sharply and by design: 100 mg per kg orally produces a two-and-a-half to three-fold rise within four to six hours ^[6][7][8], and even 500 g of cottage cheese raised it 28.7% in healthy women ^[9]. Whether that matters is genuinely mixed and should not be overstated in either direction. Genetic evidence using MTHFR across 48,175 coronary cases found essentially no causal effect on coronary heart disease ^[10], and lowering homocysteine with folic acid in 37,485 randomised participants reduced no vascular events ^[11]; but in a low-folate cohort of 156,253 adults the same genotype carried 13% higher stroke risk, weighted toward haemorrhagic stroke ^[12]. Treat it as a real but modest concern pointed at stroke, and as a reason to keep B-vitamin status good.

Absolute contraindications: homocystinuria and CBS deficiency, MAT I/III deficiency and the other genetic hypermethioninaemias ^[22]. Approach only under supervision with significant liver disease, since impaired hepatic handling drives both hyperhomocysteinaemia and deficient SAMe synthesis ^[23]; with untreated B12, folate or B6 deficiency, because all three gate homocysteine disposal; in infancy; and in schizophrenia, where methionine is long established to exacerbate psychopathological symptoms ^[1]. Recent nitrous oxide exposure inactivates methionine synthase and warrants medical assessment rather than self-supplementation ^[25]. A methionine loading dose is 0.1 g per kg; a ten-fold larger dose given by mistake has caused death ^[1], which is a wide margin against any supplement dose but establishes that this is not a substance where more is harmlessly more.

Methionine was identified as an essential amino acid during the classical nutrition work of the 1930s and 1940s, and its place in the methylation cycle was mapped over the following decades. Its clinical moment came in the 1970s, when oral methionine was shown to prevent liver injury after paracetamol overdose if given within about ten hours, by supplying the cysteine that glutathione synthesis is rate-limited by ^[20]. Acetylcysteine later became standard care, and Cochrane's review of the antidotes concludes acetylcysteine should be given to anyone at risk ^[20]. From 1993 the literature turned in an unexpected direction: restricting dietary methionine extended the lifespan of rats by 30%, a finding since reproduced in mice and across other species ^[13][14].

Methionine is usually sold on the strength of the SAMe connection, on the reasoning that more precursor means more methyl donor and therefore better mood and sharper thinking. The chain does not survive contact with the evidence. SAMe itself failed to separate from placebo across 14 depression trials in 1,522 people ^[18] and across 30 cognition studies ^[19], and methionine has never been tested for cognition in a human randomised trial at all ^[17]. There is also an awkward observational signal pointing the other way, with higher methionine intake associated with increased risk of mild cognitive impairment. The honest summary is that the nootropic case is pathway inference, not a finding.